The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
Abstract
The emergence of multidrug-resistant gram-negative bacteria and the lack of new antibiotics to combat them have led to the revival of polymyxins, an old class of cationic, cyclic polypeptide antibiotics. Polymyxin B and polymyxin E (colistin) are the 2 polymyxins used in clinical practice. Most of the reintroduction of polymyxins during the last few years is related to colistin. The polymyxins are active against selected gram-negative bacteria, including Acinetobacter species, Pseudomonas aeruginosa, Klebsiella species, and Enterobacter species. These drugs have been used extensively worldwide for decades for local use. However, parenteral use of these drugs was abandoned approximately 20 years ago in most countries, except for treatment of patients with cystic fibrosis, because of reports of common and serious nephrotoxicity and neurotoxicity. Recent studies of patients who received intravenous polymyxins for the treatment of serious P. aeruginosa and Acinetobacter baumannii infections of various types, including pneumonia, bacteremia, and urinary tract infections, have led to the conclusion that these antibiotics have acceptable effectiveness and considerably less toxicity than was reported in old studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Guide to the Natural History of Freshwater Lake Bacteria
Newton, R. J., Jones, S. E., Eiler, A., McMahon, K. D., & Bertilsson, S. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00028-10 · Cited by 1,585
British Journal of Pharmacology
(2010) · British Journal of Pharmacology · doi:10.1111/(issn)1476-5381 · Cited by 920
Polymyxin and Related Peptide Antibiotics
Storm, D. R., Rosenthal, K. S., & Swanson, P. E. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003451 · Cited by 759
Gunn, J. S., Lim, K. B., Krueger, J., Kim, K., Guo, L., Hackett, M., & Miller, S. I. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00757.x · Cited by 655
Levin, A. S., Barone, A. A., Penço, J., Santos, M. V., Marinho, I. S., Arruda, E. A. G., Manrique, E. I., & Costa, S. F. (1999) · Clinical Infectious Diseases · doi:10.1086/514732 · Cited by 612
The peptide antibiotics of Bacillus: chemistry, biogenesis, and possible functions
Katz, E., & Demain, A. L. (1977) · Bacteriological Reviews · doi:10.1128/br.41.2.449-474.1977 · Cited by 540
Garnacho‐Montero, J., Ortiz‐Leyba, C., Jimenez‐Jimenez, F. J., Barrero‐Almodovar, A. E., Garcia‐Garmendia, J. L., Bernabeu‐WittelI, M., Gallego‐Lara, S. L., & Madrazo‐Osuna, J. (2003) · Clinical Infectious Diseases · doi:10.1086/374337 · Cited by 470
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS: 2007 INSTRUCTIONS TO AUTHORS
(2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00038-06 · Cited by 420
Gales, A. C., Reis, A. O., & Jones, R. N. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.183-190.2001 · Cited by 382
THE PROPERTIES AND MODE OF ACTION OF THE POLYMYXINS
Newton, B. A. (1956) · Bacteriological Reviews · doi:10.1128/br.20.1.14-27.1956 · Cited by 349
Interaction of divalent cations and polymyxin B with lipopolysaccharide
Schindler, M., & Osborn, M. J. (1979) · Biochemistry · doi:10.1021/bi00587a024 · Cited by 334
Michalopoulos, A. S., Tsiodras, S., Rellos, K., Mentzelopoulos, S., & Falagas, M. E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01043.x · Cited by 292
Self-citationRegulation of polymyxin resistance and adaptation to low-Mg2+ environments
Groisman, E. A., Kayser, J., & Soncini, F. C. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.22.7040-7045.1997 · Cited by 282
Markou, N., Apostolakos, H., Koumoudiou, C., Athanasiou, M., Koutsoukou, A., Alamanos, I., & Gregorakos, L. (2003) · Critical Care · doi:10.1186/cc2358 · Cited by 278
Antiendotoxin activity of cationic peptide antimicrobial agents
Gough, M., Hancock, R. E., & Kelly, N. M. (1996) · Infection and Immunity · doi:10.1128/iai.64.12.4922-4927.1996 · Cited by 244
Toxicity after prolonged (more than four weeks) administration of intravenous colistin
Falagas, M. E., Rizos, M., Bliziotis, I. A., Rellos, K., Kasiakou, S. K., & Michalopoulos, A. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-1 · Cited by 242
Self-citationMichalopoulos, A., Kasiakou, S. K., Mastora, Z., Rellos, K., Kapaskelis, A. M., & Falagas, M. E. (2004) · Critical Care · doi:10.1186/cc3020 · Cited by 209
Self-citation(1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603000125 · Cited by 185
Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use
Al-Aloul, M., Miller, H., Alapati, S., Stockton, P. A., Ledson, M. J., & Walshaw, M. J. (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20138 · Cited by 178
Electron microscopic studies on mode of action of polymyxin
Koike, M., Iida, K., & Matsuo, T. (1969) · Journal of Bacteriology · doi:10.1128/jb.97.1.448-452.1969 · Cited by 172
Bengoechea, J. A., & Skurnik, M. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01956.x · Cited by 169
Me, J.-M., Pichardo-Guerrero, C., Márquez-Rivas, J., Martín-Lozano, D., Prados, T., & Pachón, J. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-001-0680-2 · Cited by 145
Conway, S. P., Pond, M. N., Watson, A., Etherington, C., Robey, H. L., & Goldman, M. H. (1997) · Thorax · doi:10.1136/thx.52.11.987 · Cited by 136
SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINS
Barnett, M., Bushby, S. R. M., & Wilkinson, S. (1964) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1964.tb01610.x · Cited by 134
Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance
Moore, R. A., & Hancock, R. E. W. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.6.923 · Cited by 133
Significance of Serum Protein and Tissue Binding of Antimicrobial Agents
Craig, W. A., & Kunin, C. M. (1976) · Annual Review of Medicine · doi:10.1146/annurev.me.27.020176.001443 · Cited by 104
Nord, N. M., & Hoeprich, P. D. (1964) · New England Journal of Medicine · doi:10.1056/nejm196405142702002 · Cited by 97
Production of β-Lactamase Inhibitors by Streptomyces Species
Marques, D. D. A. V., Machado, S. E. F., Santos‐Ebinuma, V. C., Duarte, C. D. A. L., Converti, A., & Porto, A. L. F. (2018) · Antibiotics · doi:10.3390/antibiotics7030061 · Cited by 81
Serological and molecular evidence of Rickettsia helvetica in Denmark
Nielsen, H., Fournier, P., Pedersen, I. S., Krarup, H. B., Ejlertsen, T., & Raoult, D. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410020776 · Cited by 72
A ten year review of Colomycin
Littlewood, J. M., Koch, C., Lambert, P. A., Høiby, N., Elborn, J. S., Conway, S. P., Dinwiddie, R., & Duncan-Skingle, F. (2000) · Respiratory Medicine · doi:10.1053/rmed.2000.0834 · Cited by 72
Kasiakou, S. K., Rafailidis, P. I., Liaropoulos, K., & Falagas, M. E. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.05.008 · Cited by 70
Self-citationHoeprich, P. D. (1970) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)32591-3 · Cited by 69
Giamarellos‐Bourboulis, E. J., Karnesis, L., & Giamarellou, H. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00443-1 · Cited by 58
The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves
Ziv, G., Nouws, J. F. M., & van Ginneken, C. A. M. (1982) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.1982.tb00497.x · Cited by 56
Price, M. E., & Weinberg, J. (1996) · ScholarlyCommons (University of Pennsylvania) · Cited by 33
Antimycobacterial spectrum of colistin (polymixin E)
Rastogi, N., Blom-Potar, M.-C., & David, H. L. (1986) · Research in Microbiology · doi:10.1016/s0769-2609(86)80004-7 · Cited by 18
Cited by
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Metadata
- Authors
- Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-01
- Volume
- 40
- Issue
- 9
- Pages
- 1333-1341
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2117795567
- Cited by
- 1,744
- References
- 36
- FWCI
- 22.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.